ICAP M&E MASTER SLIDE DECK
DATA THROUGH DECEMBER 31, 2011
2
CONTENTS
Site Census Slide 3
Care and Treatment Indicators Slide 6
PMTCT Indicators Slide 51
Indicators for TB Screening in HIV Care Settings Slide 61
Indicators for HIV Testing in TB Patients Slide 69
Indicators for HIV Testing and Counseling Slide 74
Indicators for Clinical Laboratories Slide 87
SITE CENSUS• What: Ongoing, real-time inventory of all planned, current, and closed ICAP facilities. Supported activities, funding source(s) and their targets are also captured
• Purpose: To have one up to date master list of facilities, activities, funding sources, and targets that all ICAP staff can refer to for planning and evaluation
NUMBER OF SELECTED ACTIVITIES AT SUPPORTED FACILITIES,
AS OF DECEMBER 31, 2011
Num
ber o
f fac
ilitie
s
Source: ICAP Site Census, February 2011Note: Some facilities offer more than one activity.
Total distinct facilities
Care & treatment
TB screening for HIV pts
HIV testing for TB pts
PMTCT Early infant diagnosis
PICT/VCT Lab0
500
1,000
1,500
2,000
2,500
3,000
2706
1003 938
592
2104
1252
1,010
500
Num
ber o
f fac
ilitie
s
NUMBER OF FACILITIES BY COUNTRY, AS OF DECEMBER 31, 2011
Source: ICAP Site Census, February 2011
Kenya Tanzania Ethiopia Mozambique
Lesotho Cote d'Ivoire
South Africa
Swaziland Nigeria DR Congo Rwanda0
100
200
300
400
500
600
700
800
900
1000977
772
277
188127 112 99
64 59 256
Num
ber o
f fac
ilitie
sNUMBER OF FACILITIES EVER SUPPORTED BY ICAP AND TRANSITIONED AS OF SEPTEMBER
2011
Source: Source: ICAP Site Census, February 2011Notes: In transition: A facility may be partially supported by an NGO or MOH but ICAP is still the prime for support and reports directly to Atlanta under MCAP. Completed transition: ICAP is no longer the prime and there is a new mechanism for supporting the site and reporting to USG (e.g., NGO, MOH or another partner).
Overall Cote d'Ivoire DR Congo Ethiopia Kenya Lesotho Mozambique Nigeria Rwanda South Africa Swaziland Tanzania0
500
1,000
1,500
2,000
2,500
3,000
3,500
Active Transitioned Unknown
CARE AND TREATMENT INDICATORS
PROGRAM AND FACILITY CHARACTERISTICS TRACKING
SYSTEM (PFACTS)What: Collects program and facility information
on ICAP-supported care and treatment programs annually
Purpose: To describe the scope, diversity, and comprehensiveness of ICAP-supported care and treatment programs, and evaluate multi-level factors that influence program performance and patient-level outcomes
Perc
ent o
f clin
ics
Source: ICAP PFaCTS Round 6, February 2011. Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.
HIV CARE AND TREATMENT CLINICS: GEOGRAPHIC LOCATION AND TYPE OF
FACILITY (n=796)
Urban 145
Semi-urban258
Rural393
0%
50%
100%
42% 47%68%
32%38%
13%12%14% 14% 19%
Public primary Public secondary Public tertiary Private/Other
Perc
ent o
f clin
ics
Source: ICAP PFaCTS Round 6, February 2011. Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.
GEOGRAPHIC LOCATION OF HIV CARE AND TREATMENT FACILITIES, BY COUNTRY
Overall n=796
Cote d'Ivoire
n=63
DR Congo
n=17
Ethiopia n=75
Kenya n=221
Mozambique
n=64
Nigeria
n=42
Rwanda
n=48
South Africa
n=80
Swaziland
n=59
Tanzania
n=127
0%
50%
100%
18%32%
82%
39%
1%
55%
19%29%
21%
7%1%
32%
59%
18%
39%
19%
16%
62%
6%
48%
15%
49%
49%
10%23%
80%
30%19%
65%
31%
78%
50%
Urban Semi-urban Rural
Perc
ent w
ith s
ervic
esPROPORTION OF HIV CARE AND TREATMENT
CLINICS* OFFERING OTHER HIV-RELATED SERVICES (n=789)
Source: ICAP PFaCTS Round 6, February 2011. Note: *“Facility” refers to the larger institution, while “clinic” refers to the unit where care and treatment is provided. **PICT is available at one or more points of service in the facility.
VCT PICT** PMTCT in ANC TB treatment75%
80%
85%
90%
95%
100%
95%
99%
94%
84%
PROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT
SERVICES (n=789)
Perc
ent w
ith s
ervic
e
Source: ICAP PFaCTS Round 6, February 2011.Notes: Facilities with missing data are excluded. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel. Nutritional treatment or support for children/infants: provision of nutritional supplements or weaning foods. Nutritional treatment for adults: provision of nutritional supplements or therapeutic foods, e.g. Plumpy’Nut. Food rations: provision of rations, e.g. snacks or food packets to promote ART adherence or household food security.
ART adherence counseling
Outreach for missed visits
Peer educator program
Nutritional treatment for
children and in-fants
Nutritional treatment for
adults
Food rations for adults or chil-
dren
0%
50%
100% 95% 91%
77%
51%
40%
24%
Source: ICAP PFaCTS Round 6, February 2011.Note: Laboratory services offered: Within the facility: specimen collection and testing done within this facility.At another facility: specimen collection done within this facility and testing conducted at another facility or both specimen collection and testing are conducted at another facility.
AVAILABILITY OF LABORATORY ASSAYS AT FACILITIES (n=796)
Perc
ent o
f fac
ilitie
s
CD4 count Hemoglobin / Hematocrit
Creatinine Hepatitis B sur-face antigen
Liver enzyme test
Infant diagnosis / PCR
Sputum smear for TB
HIV-RNA0%
50%
100%
23%
69%
30% 27% 30%
2%
65%
2%
77%
31%
70% 73% 70%
93%
34%
62%
5% 1%
37%
Available within the facility Available at another facility Not available
MEAN NUMBER OF FULL-TIME HEALTH CARE PROVIDERS AT HIV CARE AND TREATMENT
CLINICS (n=782)
Mea
n nu
mbe
r of p
rovid
ers
Source: ICAP PFaCTS Round 6, February 2011.
Overall Nigeria Mozambique
DR Congo South Africa
Ethiopia Cote d'Ivoire
Swaziland Rwanda Kenya Tanzania0.0
2.0
4.0
6.0
8.0
10.0
12.0
0.61.6 1.5 1.4
0.5 0.61.2
0.4 0.4
1.6
4.1
1.5
3.1
3.3
1.71.5
2.0 1.5
0.9 0.7
0.9
4.3
2.70.4
0.1
0.0 0.1
1.10.6
Physicians NursesHealth Officers / Medical Assistants
MEAN NUMBER OF OUTREACH WORKERS AT ICAP-SUPPORTED
HIV CARE AND TREATMENT CLINICS WITH OUTREACH PROGRAMS (n=649*)
Mea
n nu
mbe
r of o
utre
ach
work
ers
Source: ICAP PFaCTS Round 6, February 2011.Note: *Only facilities with outreach programs
Overall South Africa
Mozambique
Nigeria Côte d'Ivoire
Kenya Ethiopia DR Congo Rwanda Swaziland Tanzania0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
1.3
3.63.4
2.0
1.4
0.9
0.7 0.6 0.5 0.5
0.2
PROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT
SERVICES OVER TIME (n=431*)
Source: ICAP PFaCTS Round 6, February 2011. Notes: *Only clinics that submitted all three rounds of data collection are included. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel.
0%
50%
100% 97%
69%63%
32%
49%
98%92%
83%
55%
72%
96% 98%
88%
50%
72%
Round 4 Round 5 Round 6
Perc
ent w
ith S
ervi
ce
Overall South Africa Ethiopia Rwanda Tanzania DR Congo Kenya Swaziland Nigeria Côte d'Ivoire
0%
50%
100%
49%
93% 93%
65%
38%
12%
67%
20%
14%
71%
96% 96% 94% 92%
82%
72%68%
55%
22%
ART initiation
Follow-up
Source: ICAP PFaCTS Round 6, February 2011.
PROPORTION OF HIV CARE AND TREATMENT CLINICS
WHERE NURSES PRESCRIBE ARVS, BY TYPE OF VISIT (n=790)
Perc
ent o
f clin
ics
CARE AND TREATMENT QUARTERLY AGGREGATE M&E
INDICATORSWhat: Collects information from ICAP-supported
clinics on a quarterly basis.
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements. 43 collected indicators include care enrollment, ART initiation and enrollment, regimen information, and ART CD4 cohort information.
HIV CARE AND TREATMENT SERVICES AT FACILITIES, AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012.Note: Closed facilities includes facilities that have transitioned to MoH, a local NGO, or another implementing partner. Closed facilities also include clinics previously supported through the MTCT+ Initiative.
Countries Facilities Ever enrolled in HIV care
Ever initiating ART
At current facilities
10 757 1,018,204 499,195
At current and closed facilities
15 992 1,403,939 708,689
CARE AND TREATMENT CLINICS REPORTINGAS OF DECEMBER 31, 2011
Source: ICAP URS February 2012.
Country Facilities supported Facilities reporting
Côte d’Ivoire 65 65
DR Congo 13 5
Ethiopia 275 69
Kenya 284 282
Mozambique 66 66
Nigeria 8 5
Rwanda 5 5
South Africa 96 77
Swaziland 64 56
Tanzania 127 127
TOTAL 1003 757 (75%)
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
0
100
200
300
400
500
600
700
800
New care enrollment New ART initiation Care and treatment clinics currently reporting
NEW ENROLLMENT IN HIV CARE AND TREATMENT, BY QUARTER
Source: ICAP URS February 2012.Note: New enrollment includes adults and children. New on treatment include patients who transfer in already on ART. Data are only from clinics currently supported and reporting. The country arrows depict when the country began contributing data.
Num
ber o
f new
pat
ient
s
30,889 initiating ART
58,200 enrolling in
care
757clinics
Number of clinics
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
0
100
HIV Care ART
CUMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT
Source: ICAP URS February 2012.Notes: Data are only from clinics supported and reporting. The country arrowss depict when the country began contributing data.
Num
ber o
f pat
ient
s Number of clinics
499,194 on ART
1,018,204 in care
757clinics
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
0
100
200
300
400
500
600
700
800
HIV care ARTCare and treatment clinics currently reporting
45,107 on ART
CUMULATIVE PEDIATRIC ENROLLMENT IN HIV CARE AND TREATMENT
Source: ICAP URS February 2012.Note: Includes adults and children. Data are only from clinics currently supported and reporting. The country boxes depict when the country began contributing data.
Num
ber o
f pat
ient
s Number of clinics
89,899in care
757clinics
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
CUMULATIVE ENROLLMENT IN HIV CARE, BY COUNTRY
(n= 1,018,435)
South Africa
Lesotho
Kenya
Tanzania
Rwanda
Nigeria
Num
ber o
f pat
ient
s
DRC
Source: ICAP URS February 2012.Notes: Data is only from care and treatment clinics supported by ICAP and reporting.
Côte d’Ivoire
Ethiopia
Mozambique
Swaziland
38596
38961
39326
39692
40057
40422
40787
0
20,000
40,000
60,000
80,000
100,000
120,000
Mozambique
South Africa
Ethiopia
Kenya
Tanzania
Rwanda
Nigeria
Swaziland
Num
ber o
f pat
ient
sCUMULATIVE ENROLLMENT ON ART, BY
COUNTRY (n=534,124)
Côte d’Ivoire
Source: ICAP URS February 2012.Notes: Data are only from clinics supported and reporting.
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
100,000
200,000
300,000
400,000
500,000
600,000
ART patients currently retained in HIV care*
CUMULATIVE PATIENTS INITIATED ON ART AND THEIR CURRENT STATUS,
AS OF DECEMBER 31, 2011 (n= 499,195)
Num
ber o
f pat
ient
s
Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting. Data include patients who have temporarily stopped ART for clinical reasons, but are continuing in HIV care.
Cumulative ever initiating ART
Reported dead
Lost to follow-up
De Ju De Ju De Ju De Ju De Ju De Ju De Ju De0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
De Ju De Ju De Ju De Ju De Ju De Ju De Ju De0
100,000
200,000
300,000
400,000
500,000
600,000Total care enrollment (n= 1,018,204 ) Total ART enrollment (n= 499,195 )
CUMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT PROGRAMS, BY ART STATUS,
AGE, AND SEX
Men 15+
Women 15+
Children <15Children <15
Men 15+
Women 15+
Source: ICAP URS February 2012Notes: Data is only from care and treatment clinics supported and reporting.
61%
30%
9%
59%
32%
9%
CUMULATIVE ART INITIATION BY SEX AT ICAP-SUPPORTED FACILITIES IN 10 SUB-SAHARAN
AFRICAN COUNTRIES
Women (n= 316,706) Men (n= 182,489)
Source: ICAP URS February 2012Notes: Data is only from care and treatment clinics supported by ICAP and reporting.
Num
ber o
f pat
ient
s
De Ju De Ju De Ju De Ju De Ju De Ju De Ju De0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
De Ju De Ju De Ju De Ju De Ju De Ju De Ju De0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Source: URS February 2011Notes: Data are only from clinics currently supported and reporting.
PROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE WHO EVER
INITIATED ART, AS OF DECEMBER 31, 2011
Perc
ent o
f pat
ient
s
Overall n=1018204
DR Congo n=3074
Rwanda n=3184
Ethiopia n=114333
South Africa n=101591
Cote d'Ivoire n=15137
Tanzania n=81488
Swaziland n=73558
Nigeria n=8042
Kenya n=260672
Mozambique
n=357125
0%
50%
100%
49%
86%
63% 61% 60% 58% 56%53% 51% 50%
38%
PROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE,
BY ART STATUS, AGE AND SEX, AS OF DECEMBER 31, 2011
Perc
ent o
f pa
tient
s
Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting.
Pre-ART n=501435
ART n= 499195
Overall n=1018204
0%
50%
100%
63% 59% 61%
29% 32% 30%
8% 9% 9%
Women 15+ Men 15+ Children <15
CUMULATIVE ENROLLMENT IN CARE, BY COUNTRY, AGE, AND SEX, AS OF DECEMBER
31, 2011
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012Note: Data are only from clinics currently supported and reporting.
Overall n=499195
Cote d'Ivoire
n=8791
South Africa n=61067
Nigeria n=4116
Tanzania n=45345
Kenya n=130773
Swaziland n=38749
Mozam-bique n=135639
DR Congo n=2651
Ethiopia n=70050
Rwanda n=2014
0%
50%
100%
59%66% 64% 63% 59% 59% 59% 58% 56% 53% 53%
32%28% 31% 33%
32% 29% 32% 33%26%
39%
18%
9% 5% 6% 4% 8% 12% 10% 9%17%
8%
28%
Women 15+ Men 15+ Children <15
Perc
ent o
f pat
ient
sCUMULATIVE ART INITIATION, BY COUNTRY,
AGE, AND SEX, AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012Note: Data are only from clinics currently supported and reporting.
Overall n=1018204
Cote d'Ivoire
n=15137
South Africa
n=101591
Nigeria n=8042
Tanzania n=81488
Kenya n=260672
Mozam-bique
n=357125
Swaziland n=73558
Ethiopia n=114333
Rwanda n=3184
DR Congo n=3074
0%
50%
100%
61%70% 66% 63% 62% 61% 61% 59% 55% 55% 54%
30%26% 30%
29% 31% 28% 31%29% 36%
20% 25%
9% 5% 5% 8% 7% 11% 8% 12% 8%
25%21%
Women 15+ Men 15+ Children <15
De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De0%
5%
10%
0.4%1.0%
1.5%
3.2%
4.5%
7.2%6.7%
4.7%
PREGNANT WOMEN AS A PROPORTION OF ALL WOMEN INITIATING ART
Source: ICAP URS February 2012
By Country, October-December 2011
Over Time
Perc
ent o
f wo
men
Perc
ent o
f wom
en
Cote d'Ivoire n=5845
DR Congo n=1496
Ethiopia n=37333
Kenya n=77390
Mozambique n=79277
Nigeria n=2592
Rwanda n=1071
South Africa n=38908
Swaziland n=22760
Tanzania n=26965
0%
10%
7%
3%2%
5%
7%
1%
9%
5%
0%
4%
Perc
ent o
f pe
diat
ric p
atie
nts
CUMULATIVE PEDIATRIC HIV CARE ENROLLMENT,
AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Overall
n=89937
Swaziland n=9081
Mozambique n=29352
Cote d'Ivoire
n=714
DR Congo n=692
Tanzania n=5984
Kenya
n=28321
Rwanda n=802
Ethiopia
n=9446
South Africa
n=4931
Nigeria n=614
0%
50%
100%
30%
44% 43%33%
28% 26% 21% 17% 17% 14%2%
25%
20% 22%
27%36%
26%29%
19%30%
21%
3%
42%33%
26%40% 38%
48% 50%
64%53%
66%
95%
0-1 year 2-4 years 5-14 years unknown
CUMULATIVE PEDIATRIC ART ENROLLMENT, AS OF DECEMBER 31, 2011
Perc
ent p
edia
tric
patie
nts
on A
RT
Source: ICAP URS February 2012
Overall
n=45129
Cote d'Ivoire n=466
Mozam-bique n=11984
Tanzania
n=3651
DR Congo n=477
Rwanda n=572
Ethiopia
n=5356
Kenya n=15189
South Africa n=3510
Nigeria n=169
Swaziland n=3755
0%
50%
100%
21%35% 35%
22% 19% 18% 18% 16% 13% 8%
27%
25% 24%
24% 34%
21% 26% 28%22%
78%
50%
40%31% 54% 46%
61% 56% 56%68%
10%
2%11%
2%4%
0-1 year 2-4 years 5-14 years unknown
ART INITIATION AMONG PATIENTS ELIGIBLE FOR ART IN ICAP-SUPPORTED PROGRAMS,
OCTOBER-DECEMBER 2011
Perc
ent p
atie
nts
elig
ible
for A
RT
Source: ICAP URS February 2012Note: Eligible, but not started: Number in HIV care during the quarter and eligible for ART but NOT started ART by the end of the quarter. Eligible, started: All those who were eligible and started on ART during the reporting quarter.
Overall n=23933
Tanzania n=2232
Kenya n=6485
Ethiopia n=2070
Mozambique n=6864
DR Congo n=251
South Africa n=3689
Cote d'Ivoire n=583
Nigeria n=235
Rwanda n=64
Swaziland n=1460
0%
50%
100%
9%16% 15%
9% 7% 5%
91%84% 85%
91% 93% 95% 98% 100% 100% 100% 100%
% eligible, not started ART % eligible, started ART
REGIMENS USED BY CURRENT ART PATIENTS, OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting.
Overall (Adults)n = 260,123
Overall (Children)n = 27,220
1st line regimen 238,091 (92%) 23,560 (87%)
d4T-3TC-NVP 57,821 (22%) 7,226 (27%)
d4T-3TC-EFV 30,836 (12%) 2,175 (8.0%)
ZDV-3TC-NVP 91,008 (35%) 7,892 (29%)
ZDV-3TC-EFV 14,103 (5.4%) 1,190 (4.4%)
Other 44,323 (17%) 5,077 (19%)
2nd line regimen 1,547 (0.6%) 323 (1.2%)
Unknown regimen 20,485 (7.9%) 3,337 (12%)
REGIMENS USED BY CURRENT ADULT ART PATIENTS BY COUNTRY,
OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Notes: * In South Africa, D4T-3TC-LPV/r , ZDV-ddl-LPV/r , and ABC-ddl-LPV/r are prescribed as a first-line regimen for pediatric patients. ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.
Côte d'Ivoire Ethiopia Kenya Mozambique Nigeria^ Rwanda South Africa*
Swaziland Tanzania
n=5,828 n=37,893 n=76,091 n=65,777 n=3,923 n=1,173 n=46,212 n= 35,841 n=23,226
1st line regimen
5,757 37,243 75,244 63,895 150 1,125 33,312 0 21,365
(99%) (98%) (99%) (97%) (3.8%) (96%) (72%) 0.0%) (92%)
2nd line regimen
16 431 548 237 1 30 166 0 118
(0.3%) (1.1%) (0.7%) (0.4%) (0.0%) (2.6%) (0.4%) (0.0%) (0.5%)
Unknown55 219 299 1,645 3,772 18 12,734 35,841 1,743
(0.9%) (0.6%) (0.4%) (2.5%) (96%) (1.5%) (28%) (100%) (7.5%)
REGIMENS USED BY CURRENT PEDIATRIC ART PATIENTS BY COUNTRY,
OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Notes: ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.
Côte d'Ivoire Ethiopia Kenya Mozambique Nigeria^ Rwanda South Africa Swaziland Tanzania
n=340 n=3,503 n=10,315 n=7,207 n=167 n=315 n=3,171 n=3,128 n=2,202
1st line regimen
326 3,382 9,616 5,388 17 297 2,392 0 2,142
(96%) (97%) (93%) (75%) (10%) (94%) (75%) (0.0%) (97%)
2nd line regimen
12 54 190 15 0 8 22 0 22
(3.5%) (1.5%) (1.8%) (0.2%) (0.0%) (2.5%) (0.7%) (0.0%) (1.0%)
Unknown2 67 509 1,804 150 10 757 3,128 38
(0.6%) (1.9%) (4.9%) (25%) (90%) (3.2%) (24%) (100%) (1.7%)
PROPORTION OF PATIENTS WITH CD4 COUNT AT
BASELINE, 6, AND 12 MONTHS AFTER ART INITIATION
(SUBSET OF ART PATIENTS*)
Perc
ent o
f pa
tient
s
Source: ICAP URS February 2012Notes: *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.
Overall n=203191
Rwanda n=803
Cote d'Ivoire n=4298
Ethiopia n=47839
South Africa n=18424
Kenya n=37324
Mozambique n=69933
Tanzania n=24570
0%
50%
100%
77%
99% 97%93% 92%
80%
65% 63%
39%
83%
58%
51% 51% 50%
25%
31%
42%
84%
50% 48%
42%
51%
33%37%
Baseline 6-month 12-month
MEDIAN CD4 COUNT AT BASELINE*, 6, AND 12 MONTHS AFTER ART INITIATION (SUBSET OF
ART PATIENTS**)
CD4
Cell C
ount
(cel
ls/ul
)
Source: ICAP URS February 2012Notes: Average of median CD4 counts at baseline and 6 and 12 months follow up are presented. * Baseline data is average of matched 6 and 12 month cohort data at baseline. ** Data only included for patients who were followed for 12 months.Data are only from clinics currently supported and reporting.
Overall n=5519
Rwanda n=613
Mozambique n=683
Lesotho n=120
Nigeria n=325
Kenya n=1143
Cote d'Ivoire n=342
South Africa n=423
Ethiopia n=825
Tanzania n=1045
0
50
100
150
200
250
300
350
400
450
150
238
174 172 169
138 135 131 130 117
263
362
330310
288255
235
262248
184
297
397
353339 347
298
254
301
275
211
Baseline 6-month 12-month
CHANGE IN MEDIAN CD4 COUNT AFTER 6 AND 12 MONTHS OF ART (SUBSET OF ART
PATIENTS*)
Chan
ge in
med
ian
CD4
coun
t (ce
lls/µ
L)
Source: ICAP URS February 2012Notes: Change in average of median CD4 counts at baseline and 6 and12 months follow up are presented. *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.
Overall Mozambique Lesotho South Africa Rwanda Ethiopia Kenya Nigeria Cote d'Ivoire Tanzania0
20
40
60
80
100
120
140
160
180
200
113
157
137 131124
118 117
105100
147
180
167 170159
145
159
178
119
6-month 12-month
Continued ART* 496,544; 83%
Discontinued ART 84,511; 17%
1%
32%
66%
7% per year on
ART
STATUS OF ART PATIENTS, AS OF DECEMBER 31, 2011
(n= 496,544)
.14% per year on
ART
Lost to follow-up
Reported dead
Stopped ART
Source: ICAP URS February 2012Notes: *Includes patients who transferred out while on ART. Data are only from clinics currently supported and reporting.
Rates
3.5% per year on
ART
REASONS FOR ART DISCONTINUATION IN ICAP-SUPPORTED HIV CLINICS, AS OF
DECEMBER 31, 2011
Perc
ent o
f disc
ontin
uing
pat
ient
s
Source: ICAP URS February 2012Notes: Excludes patients who transferred out while on ART.
Overall n=75712
Mozambique n=31294
South Africa n=3143
Kenya n=23364
Nigeria n=15
Ethiopia n=15934
Tanzania n=8799
Cote d'Ivoire n=1813
Rwanda n=149
0%
50%
100%
68% 71% 70% 70% 67% 65%50%
39% 35%
30% 28% 27% 29% 33% 34%
48%
52%49%
1% 1%1% 1% 2%
9%16%
Lost to follow-up Reported dead Stopped ART
PMTCT INDICATORS
PMTCTQUARTERLY AGGREGATE M&E
INDICATORSWhat: Collects information from ICAP-supported
facilities on a quarterly basis
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 32 indicators covering the counseling, testing, HIV results, and ultimately, the treatment of HIV positive pregnant women and their exposed infants.
PMTCT FACILITIES REPORTINGAS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Country Facilities supported Facilities reporting
Côte d’Ivoire 99 95
DRC 4 0
Ethiopia 85 83
Kenya 976 891
Mozambique 176 174
Nigeria 59 36
Rwanda 1 1
South Africa 95 87
Swaziland 22 0
Tanzania 587 587
TOTAL 2104 1954 (93%)
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0
50,000
100,000
150,000
200,000
250,000
0
500
1000
1500
2000
2500
ANC visit Tested Number of facilities
NUMBER OF PREGNANT WOMEN ATTENDING ANC AND RECEIVING HIV TESTING, JUNE
2007 – SEPTEMBER 2011
Source: ICAP URS February 2012. The country arrows depict when the country started contributing data.
1,954 clinics
164,008 HIV tests
202,656 ANC visits
Num
ber o
f wom
enNum
ber of clinics
S. Africa
Côte d’Ivoire
Mozambique, Rwanda,Ethiopia,Nigeria,
Tanzania
Kenya
Perc
ent o
f wom
enTYPE OF ART REGIMEN FOR PMTCT, BY
COUNTRY, OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012.Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks.
Overall n=8605
Cote d'Ivoire n=253
Ethiopia n=267
Mozambique n=5132
Nigeria n=66
Rwanda n=14
South Africa n=1999
Tanzania n=874
0%
50%
100%
12%20%
0%
66%83%
22%
70%
47%
29%
53%
82%
15%17%
7%
10%
21%
29%
18%7%
72%
53% 50%
18%
SD-NVP Multi-drug regimens Newly initiating ART Already on ART
TYPE OF ART REGIMEN FOR PMTCT, BY QUARTER
Perc
ent o
f wom
en
Source: ICAP URS February 2012Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks.
Sep-08 Dec-08 Mar-09 Jun-09 Sep-09 Dec-09 Mar-10 Jun-10 Sep-10 Dec-10 Mar-11 Jun-11 Sep-11 Dec-110%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
47%37%
26% 28%19% 17%
23%13% 10% 4% 8% 7% 8% 12%
49%57%
67% 65%72% 71%
64%74% 78%
80%81%
70% 68% 66%
5% 6% 7% 7% 9% 12% 12% 12% 12% 16% 11%16% 16% 15%
SD-NVP Multi-drug regimens Initiated ART
Perc
ent
PROPORTION OF HIV+ WOMEN WITH DOCUMENTED CD4 TEST RESULTS IN
CLINICS OFFERING CD4 TESTING 90% target for sites reporting CD4
Source: ICAP URS February 2012
Cote d'Ivoire Mozambique Nigeria Rwanda South Africa Tanzania0%
20%
40%
60%
80%
100%
Mean January 2010 - December 2011 Oct-Dec 2011% of sites reporting CD4
ART ELIGIBILITY AND INITIATION OF ART AMONG
HIV+ PREGNANT WOMEN
Num
ber o
f wom
en
Source: ICAP URS February 2012Notes: Data is not available for all indicators in all countries.
Mozambique Kenya South Africa Tanzania Cote d'Ivoire Nigeria Ethiopia0
1,000
2,000
3,000
4,000
5,000
6,000
# HIV+
# assessed through clinical staging or CD4 testing
# enrolled in C&T
# eligible for ART
# newly initiating ART
HIV EXPOSED INFANTS, OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Notes: Data is not available for all indicators in all countries. HIV exposed infants includes women who tested positive in ANC and those who tested positive in maternity during the quarter.
Series10
2,000
4,000
6,000
8,000
10,000
12,000
14,000 13,255
6,465
4,937 4,465
65 139
HIV Exposed Infants
# received prophylaxis
# received CTX
# HEI PCR tested < 2 mos.
PCR tested HIV+
# infants intitiating ART
Indicators for TB Screening in HIV Care
SettingsWhat: Collects information from ICAP-supported facilities on a quarterly basis
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements, through 12 collected indicators.
TB SCREENING IN HIV CARE SETTINGSAS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Country Clinics supported Clinics reporting
Côte d’Ivoire 65 58
DR Congo 9 .
Ethiopia 85 67
Lesotho 127 .
Kenya 296 283
Mozambique 61 61
Nigeria 8 6
Rwanda 5 5
South Africa 95 87
Swaziland 60 .
Tanzania 127 127
TOTAL 938 694 (74%)
PROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB,
OCTOBER-DECEMBER 2011
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting. New HIV care patients excludes patients who knew their TB status.
New HIV care patients Overall
n=37433Tanzania
n=3531Rwanda
n=117South Africa
n=8219Kenya
n=9339Cote d'Ivoire
n=1096Mozambique n=14687
Nigeria n=444
0%
50%
100%
75%
100% 99%
89% 88%
74%
55%
26%
PROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB,
BY QUARTER
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012Note: Côte d’Ivoire began reporting in April-June 2008 quarter and South Africa began in July-September 2008 quarter. Data are only from clinics currently supported and reporting. As of March 2010, new HIV care patients excludes patients who knew their TB status at enrollment.
Number of clinics
New HIV care patients with
unknown status
Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09 Jun-09 Sep-09 Dec-09 Mar-10 Jun-10 Sep-10 Dec-10 Mar-11 Jun-11 Sep-11 Dec-110%
20%
40%
60%
80%
100%
0
100
200
300
400
500
600
700
63% 61%66% 66%
69%63% 66%
71% 69% 72% 74%78%
73% 74%78%
83%
75%
Proportion # clinics
PROPORTION OF ALL HIV PATIENTS SCREENED FOR TB WHO SCREENED
POSITIVE, OCTOBER-DECEMBER 2011
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012
Patients Screened
Overall n=27464
Mozambique n=7964
South Africa n=7016
Nigeria n=114
Tanzania n=3525
Cote d'Ivoire n=783
Rwanda n=116
Kenya n=7946
-10%
0%
10%
20%
30%
16%
21% 20% 19%18%
10%9%
6%
Patients screened positive
PROPORTION OF ALL NEW HIV PATIENTS WITH A POSITIVE TB SCREEN WHO INITIATED
TB TREATMENT, OCTOBER-DECEMBER 2011
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012
Overall n=4299
Nigeria n=22 South Africa n=1416
Tanzania n=638
Kenya n=493 Mozambique n=1643
Cote d'Ivoire n=77
Rwanda n=100%
10%
20%
30%
40%
50%
60%
70%
29%
64%
47%
27%24%
16%
10% 10%
PROPORTION OF ALL NEW HIV CARE PATIENTS WHO INITIATED TB TREATMENT,
OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Note: Although Ethiopia does not report other TB indicators, they do report diagnosis data and are therefore included in this graph. Data are only from clinics currently supported and reporting.
Perc
ent o
f pat
ient
s
New HIV care patients
Overall n=40229
South Africa n=8219
Tanzania n=3531
Ethiopia n=2796
Mozam-bique n=14687
Kenya n=9339
Cote d'Ivoire n=1096
Rwanda n=117
Nigeria n=444
0%
10%
20%
10%
16%
14%
12%
9%8%
6%
3%
0%
INDICATORS FOR HIV TESTING IN TB
PATIENTSWhat: Collects information from ICAP-supported facilities on a quarterly basis
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 16 collected indicators.
HIV TESTING IN TB CLINICS, AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Country Facilities supported Facilities reporting
Côte d’Ivoire 16 14
DR Congo 12 10
Ethiopia 85 83
Kenya 296 283
Lesotho 17 17
Mozambique 56 56
Nigeria 8 6
Rwanda 2 2
South Africa 92 85
TOTAL 584 556 (95%)
PROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS TESTED FOR HIV,
OCTOBER-DECEMBER 2011
Perc
ent o
f pa
tient
s
New TB patients w/
unknown HIV status
Source: ICAP URS February 2012
Overall n=13973
Rwanda n=22
DR Congo n=468
Ethiopia n=2507
Kenya n=2498
Lesotho n=3119
South Africa
n=3411
Cote d'Ivoire
n=384
Nigeria n=41
Mozam-bique n=1523
0%
50%
100%
85%
100%
89% 88% 87% 86% 86% 84%78%
75%
PROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS AT ICAP-SUPPORTED TB
CLINICS TESTED FOR HIV OVER TIME
Perc
ent o
f pat
ient
s
Source: ICAP URS February 2012.
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Mar-11
Jun-11
Sep-11
Dec-11
0%
50%
100%
0
100
200
300
400
500
600
88%83%
90% 90% 90% 92% 94%88% 89%
85%81%
78%85%
77%
85%88% 85%
Proportion # clinics
PROPORTION OF TB PATIENTS WHO TESTED HIV POSITIVE,
BY COUNTRY, OCTOBER-DECEMBER 2011
Perc
ent o
f pa
tient
s
New TB patients
tested for HIV
Source: ICAP URS February 2012. Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, and Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya , and South Africa, the bar represents those new TB patients who were HIV tested at any clinic.
Tested at any clinicTested at TB clinic
Overall n=11927
Mozam-bique n=1136
Nigeria n=32
Cote d'Ivoire
n=323
DR Congo n=416
Rwanda n=22
Ethiopia n=2207
Lesotho n=2687
South Africa
n=2938
Kenya n=2166
0%
20%
40%
60%
80%
43%
36%
16%11% 10%
5% 2%
76%
61%
34%
PROPORTION OF HIV(+) TB PATIENTS ENROLLING IN HIV CARE, OCTOBER-DECEMBER 2011
Perc
ent o
f pa
tient
s
New TB patients testing positive for HIV
Source: ICAP URS February 2012. Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya, South Africa, and DR Congo, the bar represents those new TB patients who were HIV tested at any clinic.
Tested at any clinicTested at TB clinic
Overall n=3065
Rwanda n=1
Mozambique n=410
DR Congo n=41
Ethiopia n=50
Cote d'Ivoire n=34
Nigeria n=5
South Africa
n=1793
Kenya
n=731
0%
50%
100%
81%
100%
88%83% 80%
26%
0%
84%
73%
Indicators for HIV Testing and Counseling
What: Collects information from ICAP-supported facilities on a quarterly basis
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 9 indicators.
COUNSELING AND TESTING,AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Country Facilities supported Facilities reporting
Côte d’Ivoire 111 100
DR Congo 23 14
Ethiopia 85 83
Kenya 218 195
Mozambique 108 104
Nigeria 56 32
Rwanda 5 5
South Africa 97 86
Tanzania 313 313
TOTAL 1021 932 (91%)
HIV TESTING AND COUNSELING, CUMULATIVE EXPERIENCE, AS OF DECEMBER 31, 2011
Source: ICAP URS February 2012Notes: Data are not available for all indicators in all points of service.
Num
ber o
f pat
ient
s
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
4,002,6243,983,199
100%
260,0086% 124,733
48%
Pre-test counseled and testedReceived test resultsHIV+ among all clients testedHIV+ and enrolled in care and treatment
NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED
IN CARE AND TREATMENT, OVER FIVE MOST RECENT QUARTERS
Source: ICAP URS February 2012
Num
ber o
f pat
ient
s
Dec-10 Mar-11 Jun-11 Sep-11 Dec-110
100,000
200,000
300,000
400,000
500,000
600,000
469,040 505,931 504,902 528,815
529,479
29,114(6%)
35,110(7%)
31,757(6%)
30,223(6%)
34,476(6%) 13,909
(48%) 16,306(46%)
15,596(49%)
17,112(57%)
15,263(44%)
Tested and received results HIV+ HIV+ and enrolled in care and treatment
NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED IN CARE AND TREATMENT, BY SEX, OVER FIVE
MOST RECENT QUARTERS
Source: ICAP URS February 2012
Num
ber o
f pat
ient
s
Sep-10 Dec-10 Mar-11 Jul-11 Sep-11
Female Male Female Male Female Male Female Male Female Male0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
259,215
210,398
284,859
221,237
290,533
224,327
287,930
222,844
303,030
235,068
18,297(7%) 10,817
(5%)
21,349(7%) 13,761
(6%)
19,458(7%) 12,299
(5%)
18,804(7%) 11,419
(5%)
21,528(7%) 12,948
(6%) 8,449(46%)
5,460(50%)
9,994(47%)
6,312(46%)
9,378(48%)
6,218(51%)
10,517(56%)
6,595(58%)
9,390(44%)
5,873(45%)
Counseled and tested HIV+ Enrolled in care and treatment
NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED
IN CARE AND TREATMENT, BY AGE, OVER THREE MOST RECENT QUARTERS
Source: ICAP URS February 2012Notes: Sites which are not able to specify patient age are excluded.
Num
ber o
f pat
ient
s
Mar-11 Jun-11 Sep-11
Adults Children Unknown Adults Children Unknown Adults Children Unknown0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
394,046
82,185
38,629
399,534
75,352
35,888
414,243
82,270
41,585 18,862(5%) 1,340
(2%)
11,555(30%)
19,512(5%) 1,345
(2%) 9,366(26%)
21,8575%) 1,425
2%)
11,194(27%)
12,66167%) 701
(52%) 2,234(19%)
13,64770%) 660
(49%) 2,805(30%)
11,739(54%) 547
(38%) 2,977(27%)
Counseled and testedHIV+Enrolled in care and treatment
Num
ber o
f pat
ient
s
Source: ICAP URS February 2012Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall % positive found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other.
NUMBER OF ADULT AND PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF
SERVICE, OCTOBER-DECEMBER 2011
Outpatient VCT* Other** Inpatient All points of service Outreach0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
312,039
91,569
56,433 45,060
27,140
5,857 10,535(3%)
12,553(14%) 4,302
(8%) 1,790 (4%)
5,255 (19%)
41(1%)
2,552*24%)
6,362(51%)
1,022(24%)
592(33%)
4,724(90%)
11(27%)
Counseled and tested HIV+
Enrolled in care and treatment
Source: ICAP URS February 2012 Note: * Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; ** Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other.
NUMBER OF ADULT PATIENTS COUNSELED AND TESTED, BY POINT OF SERVICE,
OCTOBER-DECEMBER 2011
Num
ber o
f pat
ient
s
Outpatient VCT* Other** Inpatient All points of service Outreach0
50,000
100,000
150,000
200,000
250,000
300,000
250,345
63,690
37,530 32,065 25,660
4,953 9,707(4%)
4,465 (7%)
935(2%)
1,562(5%)
5,150 (20%)
38(1%)
2,392( 25%)
3,620(81%)
581(62%)
500(32%)
4,637(90%)
9(24%)
Counseled and tested HIV+
Enrolled in care and treatment
Source: ICAP URS February 2012 Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other .
NUMBER OF PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF
SERVICE, OCTOBER-DECEMBER 2011
Num
ber o
f pat
ient
s
Outpatient Inpatient VCT* Other** All points of service Outreach0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
61,694
12,995
3,422 1,775 1,480 904
828(1%)
228(2%)
214(6%)
47(3%)
105(7%)
3(0.3%)
160(19%)
92(40%)
175(82%)
31(66%)
87(83%)
2 (67%)
Counseled and tested HIV+
Enrolled in care and treatment
Source: ICAP URS February 2012Notes: Excludes pregnant women tested as part of PMTCT.
NUMBER OF PATIENTS RECEIVING PRE-TEST COUNSELING AND TESTING, BY COUNTRY,
OCTOBER-DECEMBER 2011
Num
ber o
f pat
ient
s
Number of facilities
Cote d'Ivoire
n= 100
DR Congo n= 14
Ethiopia n= 83
Kenya n= 195
Mozam-bique
n= 104
Nigeria n= 32
Rwanda n= 5
South Africa
n= 86
Tanzania n= 313
0
50,000
100,000
150,000
200,000
250,000
300,000
15,908462
259,204
126,414
41,585
2,792 2,839
31,757
60,687
Source: ICAP URS February 2012
PERCENT OF PATIENTS WHO WERE HIV+, BY COUNTRY,
OCTOBER-DECEMBER 2011
Perc
ent o
f pat
ient
s
Cote d'Ivoire DR Congo Ethiopia Kenya Mozambique Nigeria Rwanda South Africa Tanzania0%
10%
20%
30%
40%
9%11%
2%
6%
32%
22%
2%
20%
7%9%
6%
1%
7%
27%
18%
6%
20%
7%
Mean Oct 2009 - Oct 2011 % Positive Oct-Dec 2011
Source: ICAP URS February 2012. Note: Kenya, Rwanda, and Nigeria do not currently report enrollment or referral to HIV care data.
PERCENT OF POSITIVE PATIENTS ENROLLED INTO CARE AND TREATMENT, BY COUNTRY,
OCTOBER-DECEMBER 2011
Num
ber o
f pat
ient
s
Mozambique n= 3398
Tanzania n= 3830
Ethiopia n= 2847
DR Congo n= 29
Cote d'Ivoire n= 1359
South Africa n= 6223
0%
20%
40%
60%
80%
100%
88% 85%77%
48%41%
96%
Indicators for Clinical Laboratories
What: Collects information from ICAP-supported facilities on a quarterly basis
Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 2 indicators.
LABORATORYAS OF DECEMBER 31, 2011
Source: ICAP URS February 2012
Country Facilities supported Facilities reporting
Côte d’Ivoire 18 17
DR Congo 6 .
Ethiopia 88 .
Kenya 209 202
Mozambique 54 53
Nigeria 8 .
Rwanda 6 4
South Africa . .
Tanzania 111 91
TOTAL 500 367 (73%)
PROPORTION OF CARE AND TREATMENT FACILITIES WITH
CLINICAL LABORATORIES, OCTOBER-DECEMBER 2011
Perc
ent o
f fac
ilitie
s wi
th c
linica
l labo
rato
ries
Source: ICAP Site Census June 2011.
Number of care and treatment facilities
0%
20%
40%
60%
80%
100%100% 100%
79%73% 72%
31% 28%
15%
Num
ber o
f tes
ts
HIV-RELATED TESTS CONDUCTED BY COUNTRY,
OCTOBER-DECEMBER 2011
Source: ICAP URS February 2012Note: Nigeria did not report PCR, viral load, or EIA. Ethiopia did not report any lab tests, but they do support laboratory services.
Cote d'Ivoire Kenya Mozambique Rwanda Tanzania0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
HIV simple rapid CD4 count CD4 % AFBViral load PCR EIA
For more information, please see:
• ICAP URS
• ICAP Data Dissemination Page
• PFACTS Country Reports